Company Filing History:
Years Active: 2014
Title: Constance Dorian: Innovator in Cancer Detection Technology
Introduction
Constance Dorian is a notable inventor based in Albuquerque, NM (US). She has made significant contributions to the field of cancer detection through her innovative methods and technologies. Her work focuses on improving the accuracy of identifying dysplastic and carcinomic cells in sputum samples.
Latest Patents
Constance Dorian holds a patent for a "System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP)." This invention provides a method for determining if a sputum sample contains dysplastic or carcinomic cells. The process involves labeling the sputum sample with TCPP to stain the cells suspected of being dysplastic or carcinomic. The sample is then excited with a specific wavelength of light, and the emission is detected to identify cancerous or dysplastic cells.
Career Highlights
Constance is currently employed at Bioaffinity Technologies, Inc., where she continues to develop and refine her innovative techniques. Her work has the potential to significantly impact cancer diagnostics and improve patient outcomes.
Collaborations
Some of her notable coworkers include John Cousins and Gordon Bennett. Their collaboration enhances the research and development efforts at Bioaffinity Technologies, Inc.
Conclusion
Constance Dorian's contributions to cancer detection technology exemplify the importance of innovation in medical diagnostics. Her patented methods represent a significant advancement in the field, showcasing her dedication to improving healthcare outcomes.